CORC  > 上海中医药大学
Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways
Nie, Xu-qiang; Chen, Huai-hong; Zhang, Jian-yong; Zhang, Yu-jing; Yang, Jian-wen; Pan, Hui-jun; Song, Wen-xia; Murad, Ferid; He, Yu-qi; Bian, Ka
刊名ACTA PHARMACOLOGICA SINICA
2016
卷号37期号:4
关键词rutaecarpine metformin fat-fed, streptozotocin-treated rats metabolic syndrome type 2 diabetes hyperlipidemia insulin receptor substrate-1 AMPK acetyl-CoA carboxylase
ISSN号1671-4083
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3644058
专题上海中医药大学
推荐引用方式
GB/T 7714
Nie, Xu-qiang,Chen, Huai-hong,Zhang, Jian-yong,et al. Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways[J]. ACTA PHARMACOLOGICA SINICA,2016,37(4).
APA Nie, Xu-qiang.,Chen, Huai-hong.,Zhang, Jian-yong.,Zhang, Yu-jing.,Yang, Jian-wen.,...&Bian, Ka.(2016).Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways.ACTA PHARMACOLOGICA SINICA,37(4).
MLA Nie, Xu-qiang,et al."Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways".ACTA PHARMACOLOGICA SINICA 37.4(2016).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace